Belviq (generic name lorcaserin) is a popular prescription weight-loss drug made by Eisai Inc. to help people experiencing obesity and weight-related health issues curb their hunger. Alarmingly, a U.S. Food and Drug Administration (FDA) safety trial concluded that the drug could increase the risk of several different types of cancer, including pancreatic, lung, and colorectal cancer. As a result, the FDA issued a full recall of Belviq in February 2020.
Weight-loss drugs are not known for their safety; unfortunately, Belviq is no exception. In a five-year, double-blind study of 12,000 patients, those taking Belviq were more likely to be diagnosed with cancer than those taking a placebo (sugar pill). The FDA stated, "A range of cancer types was reported, with several different types of cancers occurring more frequently in the lorcaserin group," including:
If you or a loved one took Belviq and were diagnosed with cancer, you could be owed compensation for medical costs, pain and suffering, lost wages, and other damages. We want to fight to help you get it. Don't wait. Call today.
Yes. In February 2020, the FDA requested that manufacturer Eisai pull all Belviq and Belviq XR products from the market. Eisai has complied with the request.
Anyone taking Belviq should stop and talk to a healthcare professional about possible safer alternatives.
If you took Belviq or its generic equivalent and were diagnosed with cancer, you should consider taking legal action against the drug's manufacturer. If you meet these criteria, you may have a case:
Over the age of 18
Diagnosed with cancer after taking Belviq, Belviq XR, or another brand of lorcaserin
If a loved one took this weight loss drug and was diagnosed with cancer, you may also contact us on their behalf
Every case is unique, but people who successfully file drug or medical device lawsuits can recover compensation for some or all of the following damages: